Your browser doesn't support javascript.
loading
Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study.
Van den Bosch, Filip; Ostor, Andrew J K; Wassenberg, Siegfried; Chen, Naijun; Wang, Chen; Garg, Vishvas; Kalabic, Jasmina.
  • Van den Bosch F; Ghent University Hospital and VIB Center for Inflammation Research, Ghent, Belgium. filip.vandenbosch@ugent.be.
  • Ostor AJK; Addenbrooke's Hospital, Cambridge, UK.
  • Wassenberg S; Rheumazentrum, Ratingen, Germany.
  • Chen N; AbbVie Inc., North Chicago, IL, USA.
  • Wang C; AbbVie Inc., North Chicago, IL, USA.
  • Garg V; AbbVie Inc., North Chicago, IL, USA.
  • Kalabic J; AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany.
Rheumatol Ther ; 4(1): 85-96, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28361468
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Año: 2017 Tipo del documento: Article